FDA Approves First Treatment for Dermatomyositis by Madaline Spencer| Published on: Aug 31, 2026

https://checkrare.com/fda-approves-first-treatment-for-dermatomyositis/ The US Food and Drug Administration (FDA) has approved Lisraya (brepocitinib) 30 mg for the treatment of adults with dermatomyositis (DM).